ProShares - Ultra Nasdaq Biotechnology
ETFYour view on BIB
ProShares - Ultra Nasdaq Biotechnology
ETFProSharesSentiment
AUM (USD)
$95.43M
Expense Ratio
1.19%
Holdings
274
Sentiment
Overview for ProShares - Ultra Nasdaq Biotechnology
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- April 7, 2010
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- April 7, 2010
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- ProShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- April 7, 2010
- Domicile
- US
About this fund
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
BIB Stock Price
Key Facts
EquityExpense Ratio
1.19%
AUM
$95.43M
Fund Details
Expense Ratio
1.19%
Assets Under Management
$95.43M
NAV
$109.69 USD
Holdings
274
Average Volume
11.2K
Inception Date
April 7, 2010
Asset Class
Equity
Fund Issuer
ProShares
Domicile
US
ISIN
US74347R2141
CUSIP
74347R214
NAV Currency
USD
Expense Ratio
1.19%
Assets Under Management
$95.43M
NAV
$109.69 USD
Holdings
274
Average Volume
11.2K
Inception Date
April 7, 2010
Asset Class
Equity
Fund Issuer
ProShares
Domicile
US
ISIN
US74347R2141
CUSIP
74347R214
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.